SCHEMBL20458541

SCHEMBL20458541

Bc1cc(C#N)c(N2CCN[C@H](C)C2)nc1C1CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.37
KDM4E B2RXH2 8/20 0.36
ALDH1A1 P00352 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
HRH4 Q9H3N8 2/20 0.36
CASP1 P29466 5/20 0.35
CASP7 P55210 5/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 4/20 0.34
ALOX15 P16050 3/20 0.34
TP53 P04637 1/20 0.34
KIT P10721 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15906809 0.86 TAAR1 (0.37) TAAR1KDM4EALDH1A1MEN1KMT2A
SCHEMBL14317457 0.86 TAAR1 (0.37) TAAR1KDM4EALDH1A1MEN1KMT2A
SCHEMBL14251550 0.86 TAAR1 (0.37) TAAR1KDM4EALDH1A1MEN1KMT2A
SCHEMBL14318088 0.82 HRH4 (0.41) ALDH1A1HRH4KITPRKCQPRKCD
SCHEMBL14318090 0.76 OPRK1 (0.39) KDM4EALDH1A1HSD17B10ALOX15HPGD
SCHEMBL14315366 0.75 HRH4 (0.35) KDM4EALDH1A1MEN1KMT2AHRH4
SCHEMBL15906811 0.75 KIT (0.36) HRH4KITPRKCQPRKCDPRKCI
SCHEMBL29654298 0.74 PDE10A (0.46) TAAR1KDM4EALDH1A1MEN1KMT2A
SCHEMBL14251040 0.73 PRKCQ (0.34) TAAR1KDM4EALDH1A1MEN1KMT2A
SCHEMBL14251042 0.73 PRKCQ (0.34) TAAR1KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2721019-B1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE AGIOS PHARMACEUTICALS INC (US) 2018-08-08 EP disclosed